Search - tctmd.com

Displaying 401 - 420 of 520

Sort: Relevancy | Date

News Industry News

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

December 15, 2015

News Industry News

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

December 13, 2015

News Industry News

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

December 08, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Daily News

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

Yael L. Maxwell

November 24, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

October 26, 2015

News Industry News

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

October 15, 2015

News Conference News TCT 2015

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

October 15, 2015

News Industry News

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

October 14, 2015

News Industry News

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

October 14, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Industry News

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

October 12, 2015

News Daily News

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

October 01, 2015

News Industry News

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

September 28, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Todd Neale

September 17, 2015

News Daily News

Short-term Readmission Rates Similar After TAVR vs SAVR

Todd Neale

September 10, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

News Daily News

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

September 09, 2015

Advertisement

Study Demonstrates i-cor® Synchronized Cardiac Assist Preserves Left Ventricular (LV) Function Compared to Continuous-Flow ECLS in Cardiogenic Shock

BioVentrix Announces 30th Clinical Case Milestone for Revivent-TC™ Technology

BioVentrix Announces Milestone Achievement of its First Interventional Heart Failure Procedure for LV Volume Reduction in a Pre-Clinical Mode

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

The Next Frontier: Repositionable, Retrievable Transcatheter Valves Show Promise in Noncalcific Aortic Regurgitation

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Mast Therapeutics Initiates Phase 2 Study Of Vepoloxamer For The Treatment Of Chronic Heart Failure

Study Shows Initial Aortic Valve Replacement In Asymptomatic Patients With Severe Aortic Stenosis May be Viable Treatment Option

Initial Surgical AVR Improves Long-term Outcomes in Asymptomatic Patients With Severe AS

SHIELD I Trial Results Confirm St. Jude Medical HeartMate PHP Cardiac Assist Device Provides Consistent, Reliable Cardiac Support During High-Risk PCI Procedures

Early Human Cases With Edwards FORMA Tricuspid Repair System Presented At TCT

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

St. Jude Medical Announces CE Mark Approval for the HeartMate 3 Left Ventricular Assist System

In the Early Days of TAVR, No Mortality Penalty for Patients Treated Outside of Trial Centers

HeartMate 3™ CE Mark Trial Meets Primary Endpoint

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

Short-term Readmission Rates Similar After TAVR vs SAVR

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

在经股 TAVR 后切口部位缝合方面 ProGlide 优于 Prostar XL

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content